Skip to main content
. Author manuscript; available in PMC: 2013 Jul 9.
Published in final edited form as: Metabolism. 2010 Mar 4;60(2):227–233. doi: 10.1016/j.metabol.2009.12.030

Table 3.

Clinical, functional, cardiovascular risk, and inflammatory markers as a function of plasma adiponectin

Group 1 Group 2 Significance
Age, y 56.6 ± 2.2 60.9 ± 1.3 NS
SBP, mm Hg 129.9 ± 3.4 136.5 ± 3.7 NS
DBP, mm Hg 74.4 ± 1.9 76.4 ± 2.4 NS
LV function data
LVEF% 39.6 ± 1.9 39.9 ± 1.9 NS
LVEDD, mm 61.9 ± 1.5 58.9 ± 1.4 NS
LVEDP, mm 10.6 ± 1.4 15.1 ± 2.1 NS
LV mass index, g/m2 140.0 ± 6.8 149.3 ± 10.0 NS
BNP, pg/mL 53.1 ± 12.9 163.9 ± 42.4 NS
Cardiovascular risk factors
Total cholesterol, mg/dL 202.4 ± 8.1 191.6 ± 9.7 NS
HDL cholesterol, mg/dL 44.4 ± 2.1 50.1 ± 2.3 P = .07
LDL cholesterol, mg/dL 131.5 ± 8.1 119.5 ± 7.3 NS
Total to HDL cholesterol 4.8 ± 0.24 3.9 ± 0.18 P = .009
Plasma triglycerides, mg/dL 118.8 ± 12.7 110.4 ± 18.1 NS
BMI, kg/m2 27.9 ± 0.69 25.9 ± 0.65 P = .037
Glucose, mg/dL 108.0 ± 6.1 109.0 ± 5.9 NS
HOMA index 2.82 ± 0.27 2.61 ± 0.39 NS
Inflammatory markers
IL-6, pg/mL 1.2 ± 0.27 1.8 ± 0.45 NS
TNFα, pg/mL 7.3 ± 0.19 7.4 ± 0.42 NS
CRP, mg/dL 0.22 ± 0.052 0.52 ± 0.17 NS